| Literature DB >> 31184932 |
Yu Sun1, Zongyan Teng2, Xiaojiao Sun1, Linxue Zhang1, Jian Chen1, Bingzhu Wang1, Fangping Lu1, Ning Liu1, Miao Yu1, Shuo Peng1, Yan Wang3, Dechao Zhao4, Yajun Zhao1, Huan Ren5, Zhongyi Cheng6, Shiyun Dong1, Fanghao Lu1, Weihua Zhang1,7.
Abstract
Hydrogen sulfide (H2S), a gaseous molecule, is involved in modulating multiple physiological functions, such as antioxidant, antihypertension, and the production of polysulfide cysteine. H2S may inhibit reactive oxygen species generation and ATP production through modulating respiratory chain enzyme activities; however, the mechanism of this effect remains unclear. In this study, db/db mice, neonatal rat cardiomyocytes, and H9c2 cells treated with high glucose, oleate, and palmitate were used as animal and cellular models of type 2 diabetes. The mitochondrial respiratory rate, respiratory chain complex activities, and ATP production were decreased in db/db mice compared with those in db/db mice treated with exogenous H2S. Liquid chromatography with tandem mass spectrometry analysis showed that the acetylation level of proteins involved in the mitochondrial respiratory chain were increased in the db/db mice hearts compared with those with sodium hydrosulfide (NaHS) treatment. Exogenous H2S restored the ratio of NAD+/NADH, enhanced the expression and activity of sirtuin 3 (SIRT3) and decreased mitochondrial acetylation level in cardiomyocytes under hyperglycemia and hyperlipidemia. As a result of SIRT3 activation, acetylation of the respiratory complexe enzymes NADH dehydrogenase 1 (ND1), ubiquinol cytochrome c reductase core protein 1, and ATP synthase mitochondrial F1 complex assembly factor 1 was reduced, which enhanced the activities of the mitochondrial respiratory chain activity and ATP production. We conclude that exogenous H2S plays a critical role in improving cardiac mitochondrial function in diabetes by upregulating SIRT3.Entities:
Keywords: SIRT3; hydrogen sulfide; lysine acetylation; mitochondrial respiratory chain; type 2 diabetes
Mesh:
Substances:
Year: 2019 PMID: 31184932 PMCID: PMC6732472 DOI: 10.1152/ajpendo.00326.2018
Source DB: PubMed Journal: Am J Physiol Endocrinol Metab ISSN: 0193-1849 Impact factor: 4.310